UniProt ID | AT1A1_HUMAN | |
---|---|---|
UniProt AC | P05023 | |
Protein Name | Sodium/potassium-transporting ATPase subunit alpha-1 | |
Gene Name | ATP1A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1023 | |
Subcellular Localization |
Cell membrane, sarcolemma Multi-pass membrane protein . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
|
Protein Description | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients.. | |
Protein Sequence | MGKGVGRDKYEPAAVSEQGDKKGKKGKKDRDMDELKKEVSMDDHKLSLDELHRKYGTDLSRGLTSARAAEILARDGPNALTPPPTTPEWIKFCRQLFGGFSMLLWIGAILCFLAYSIQAATEEEPQNDNLYLGVVLSAVVIITGCFSYYQEAKSSKIMESFKNMVPQQALVIRNGEKMSINAEEVVVGDLVEVKGGDRIPADLRIISANGCKVDNSSLTGESEPQTRSPDFTNENPLETRNIAFFSTNCVEGTARGIVVYTGDRTVMGRIATLASGLEGGQTPIAAEIEHFIHIITGVAVFLGVSFFILSLILEYTWLEAVIFLIGIIVANVPEGLLATVTVCLTLTAKRMARKNCLVKNLEAVETLGSTSTICSDKTGTLTQNRMTVAHMWFDNQIHEADTTENQSGVSFDKTSATWLALSRIAGLCNRAVFQANQENLPILKRAVAGDASESALLKCIELCCGSVKEMRERYAKIVEIPFNSTNKYQLSIHKNPNTSEPQHLLVMKGAPERILDRCSSILLHGKEQPLDEELKDAFQNAYLELGGLGERVLGFCHLFLPDEQFPEGFQFDTDDVNFPIDNLCFVGLISMIDPPRAAVPDAVGKCRSAGIKVIMVTGDHPITAKAIAKGVGIISEGNETVEDIAARLNIPVSQVNPRDAKACVVHGSDLKDMTSEQLDDILKYHTEIVFARTSPQQKLIIVEGCQRQGAIVAVTGDGVNDSPALKKADIGVAMGIAGSDVSKQAADMILLDDNFASIVTGVEEGRLIFDNLKKSIAYTLTSNIPEITPFLIFIIANIPLPLGTVTILCIDLGTDMVPAISLAYEQAESDIMKRQPRNPKTDKLVNERLISMAYGQIGMIQALGGFFTYFVILAENGFLPIHLLGLRVDWDDRWINDVEDSYGQQWTYEQRKIVEFTCHTAFFVSIVVVQWADLVICKTRRNSVFQQGMKNKILIFGLFEETALAAFLSYCPGMGVALRMYPLKPTWWFCAFPYSLLIFVYDEVRKLIIRRRPGGWVEKETYY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MGKGVGRDKY -----CCCCCCCCCC | 63.38 | 23503661 | |
4 | Ubiquitination | ----MGKGVGRDKYE ----CCCCCCCCCCC | 37.67 | 23000965 | |
5 | Ubiquitination | ---MGKGVGRDKYEP ---CCCCCCCCCCCC | 6.91 | 22817900 | |
6 | Ubiquitination | --MGKGVGRDKYEPA --CCCCCCCCCCCCC | 40.51 | 22817900 | |
9 | Acetylation | GKGVGRDKYEPAAVS CCCCCCCCCCCCCCC | 50.59 | 23236377 | |
9 | Ubiquitination | GKGVGRDKYEPAAVS CCCCCCCCCCCCCCC | 50.59 | 23000965 | |
9 (in isoform 1) | Ubiquitination | - | 50.59 | 21890473 | |
9 (in isoform 2) | Ubiquitination | - | 50.59 | 21890473 | |
10 | Phosphorylation | KGVGRDKYEPAAVSE CCCCCCCCCCCCCCC | 31.28 | 27273156 | |
14 | Ubiquitination | RDKYEPAAVSEQGDK CCCCCCCCCCCCCCC | 18.98 | 22817900 | |
16 | Phosphorylation | KYEPAAVSEQGDKKG CCCCCCCCCCCCCCC | 21.34 | 23401153 | |
16 (in isoform 4) | Phosphorylation | - | 21.34 | 25849741 | |
21 | 2-Hydroxyisobutyrylation | AVSEQGDKKGKKGKK CCCCCCCCCCCCCCC | 70.96 | - | |
21 | Acetylation | AVSEQGDKKGKKGKK CCCCCCCCCCCCCCC | 70.96 | - | |
21 | Ubiquitination | AVSEQGDKKGKKGKK CCCCCCCCCCCCCCC | 70.96 | 21906983 | |
21 (in isoform 1) | Ubiquitination | - | 70.96 | 21890473 | |
21 (in isoform 2) | Ubiquitination | - | 70.96 | 21890473 | |
22 | Ubiquitination | VSEQGDKKGKKGKKD CCCCCCCCCCCCCCC | 79.35 | 22817900 | |
23 | Ubiquitination | SEQGDKKGKKGKKDR CCCCCCCCCCCCCCC | 42.52 | 21890473 | |
24 | Ubiquitination | EQGDKKGKKGKKDRD CCCCCCCCCCCCCCC | 68.20 | 22817900 | |
25 | Ubiquitination | QGDKKGKKGKKDRDM CCCCCCCCCCCCCCH | 82.00 | 22817900 | |
27 | Ubiquitination | DKKGKKGKKDRDMDE CCCCCCCCCCCCHHH | 61.45 | 23503661 | |
36 | 2-Hydroxyisobutyrylation | DRDMDELKKEVSMDD CCCHHHHHHHHCCCC | 44.85 | - | |
36 | Ubiquitination | DRDMDELKKEVSMDD CCCHHHHHHHHCCCC | 44.85 | 21906983 | |
36 (in isoform 1) | Ubiquitination | - | 44.85 | 21890473 | |
36 (in isoform 2) | Ubiquitination | - | 44.85 | 21890473 | |
37 | Ubiquitination | RDMDELKKEVSMDDH CCHHHHHHHHCCCCC | 75.79 | 21906983 | |
37 (in isoform 1) | Ubiquitination | - | 75.79 | 21890473 | |
37 (in isoform 2) | Ubiquitination | - | 75.79 | 21890473 | |
40 | Phosphorylation | DELKKEVSMDDHKLS HHHHHHHCCCCCCCC | 20.00 | 25307156 | |
45 | Ubiquitination | EVSMDDHKLSLDELH HHCCCCCCCCHHHHH | 46.92 | 21890473 | |
45 | Ubiquitination | EVSMDDHKLSLDELH HHCCCCCCCCHHHHH | 46.92 | 21890473 | |
45 | 2-Hydroxyisobutyrylation | EVSMDDHKLSLDELH HHCCCCCCCCHHHHH | 46.92 | - | |
45 | Acetylation | EVSMDDHKLSLDELH HHCCCCCCCCHHHHH | 46.92 | 26822725 | |
45 | Ubiquitination | EVSMDDHKLSLDELH HHCCCCCCCCHHHHH | 46.92 | 22817900 | |
45 (in isoform 1) | Ubiquitination | - | 46.92 | 21890473 | |
45 (in isoform 2) | Ubiquitination | - | 46.92 | 21890473 | |
47 | Phosphorylation | SMDDHKLSLDELHRK CCCCCCCCHHHHHHH | 38.28 | 21082442 | |
47 (in isoform 4) | Phosphorylation | - | 38.28 | 24719451 | |
54 | Ubiquitination | SLDELHRKYGTDLSR CHHHHHHHHCCCHHH | 36.97 | 21890473 | |
54 | Ubiquitination | SLDELHRKYGTDLSR CHHHHHHHHCCCHHH | 36.97 | 21890473 | |
54 | 2-Hydroxyisobutyrylation | SLDELHRKYGTDLSR CHHHHHHHHCCCHHH | 36.97 | - | |
54 | Acetylation | SLDELHRKYGTDLSR CHHHHHHHHCCCHHH | 36.97 | 27452117 | |
54 | Ubiquitination | SLDELHRKYGTDLSR CHHHHHHHHCCCHHH | 36.97 | 27667366 | |
54 (in isoform 1) | Ubiquitination | - | 36.97 | 21890473 | |
54 (in isoform 2) | Ubiquitination | - | 36.97 | 21890473 | |
55 | Phosphorylation | LDELHRKYGTDLSRG HHHHHHHHCCCHHHC | 25.80 | 27273156 | |
55 (in isoform 4) | Phosphorylation | - | 25.80 | 24719451 | |
57 | Phosphorylation | ELHRKYGTDLSRGLT HHHHHHCCCHHHCHH | 30.58 | 26356563 | |
60 | Phosphorylation | RKYGTDLSRGLTSAR HHHCCCHHHCHHHHH | 27.41 | 26356563 | |
60 | Ubiquitination | RKYGTDLSRGLTSAR HHHCCCHHHCHHHHH | 27.41 | 21963094 | |
61 | Methylation | KYGTDLSRGLTSARA HHCCCHHHCHHHHHH | 51.98 | - | |
65 | O-linked_Glycosylation | DLSRGLTSARAAEIL CHHHCHHHHHHHHHH | 22.32 | 29351928 | |
81 | Phosphorylation | RDGPNALTPPPTTPE CCCCCCCCCCCCCHH | 31.19 | - | |
85 | Phosphorylation | NALTPPPTTPEWIKF CCCCCCCCCHHHHHH | 61.84 | - | |
86 | Phosphorylation | ALTPPPTTPEWIKFC CCCCCCCCHHHHHHH | 25.61 | - | |
91 | Ubiquitination | PTTPEWIKFCRQLFG CCCHHHHHHHHHHHC | 39.21 | 21963094 | |
122 | Ubiquitination | YSIQAATEEEPQNDN HHHHHHCCCCCCCCC | 56.49 | 22817900 | |
125 | Ubiquitination | QAATEEEPQNDNLYL HHHCCCCCCCCCHHH | 41.37 | 23000965 | |
131 | Ubiquitination | EPQNDNLYLGVVLSA CCCCCCHHHHHHHHH | 13.99 | 23000965 | |
146 | Ubiquitination | VVIITGCFSYYQEAK HHHHHCCCHHHHHHH | 5.79 | 32015554 | |
149 | Phosphorylation | ITGCFSYYQEAKSSK HHCCCHHHHHHHHHH | 9.93 | - | |
153 | Ubiquitination | FSYYQEAKSSKIMES CHHHHHHHHHHHHHH | 55.28 | 22817900 | |
154 | Phosphorylation | SYYQEAKSSKIMESF HHHHHHHHHHHHHHH | 43.86 | 28152594 | |
155 | Phosphorylation | YYQEAKSSKIMESFK HHHHHHHHHHHHHHH | 26.04 | 28152594 | |
156 | 2-Hydroxyisobutyrylation | YQEAKSSKIMESFKN HHHHHHHHHHHHHHH | 53.84 | - | |
156 | Ubiquitination | YQEAKSSKIMESFKN HHHHHHHHHHHHHHH | 53.84 | 23000965 | |
156 (in isoform 1) | Ubiquitination | - | 53.84 | 21890473 | |
156 (in isoform 2) | Ubiquitination | - | 53.84 | 21890473 | |
160 | Phosphorylation | KSSKIMESFKNMVPQ HHHHHHHHHHHCCCC | 24.92 | 28152594 | |
162 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 21890473 | |
162 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 21890473 | |
162 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 23000965 | |
162 (in isoform 1) | Ubiquitination | - | 54.11 | 21890473 | |
162 (in isoform 2) | Ubiquitination | - | 54.11 | 21890473 | |
163 | Ubiquitination | KIMESFKNMVPQQAL HHHHHHHHCCCCCEE | 34.37 | 32015554 | |
164 | Sulfoxidation | IMESFKNMVPQQALV HHHHHHHCCCCCEEE | 4.85 | 21406390 | |
177 | Ubiquitination | LVIRNGEKMSINAEE EEEECCCCCEECCEE | 39.07 | 32015554 | |
178 | Sulfoxidation | VIRNGEKMSINAEEV EEECCCCCEECCEEE | 4.18 | 21406390 | |
181 | Ubiquitination | NGEKMSINAEEVVVG CCCCCEECCEEEEEE | 33.71 | 23000965 | |
194 | 2-Hydroxyisobutyrylation | VGDLVEVKGGDRIPA EECEEEEECCCCCCC | 43.61 | - | |
194 | Ubiquitination | VGDLVEVKGGDRIPA EECEEEEECCCCCCC | 43.61 | 32015554 | |
198 | Methylation | VEVKGGDRIPADLRI EEEECCCCCCCCEEE | 39.81 | - | |
204 | Methylation | DRIPADLRIISANGC CCCCCCEEEEECCCC | 25.41 | - | |
207 | Phosphorylation | PADLRIISANGCKVD CCCEEEEECCCCEEC | 17.20 | 29978859 | |
212 | Ubiquitination | IISANGCKVDNSSLT EEECCCCEECCCCCC | 54.76 | 21890473 | |
212 | Ubiquitination | IISANGCKVDNSSLT EEECCCCEECCCCCC | 54.76 | 21890473 | |
212 | Ubiquitination | IISANGCKVDNSSLT EEECCCCEECCCCCC | 54.76 | 23000965 | |
212 (in isoform 1) | Ubiquitination | - | 54.76 | 21890473 | |
212 (in isoform 2) | Ubiquitination | - | 54.76 | 21890473 | |
216 | Phosphorylation | NGCKVDNSSLTGESE CCCEECCCCCCCCCC | 23.43 | 23401153 | |
217 | Phosphorylation | GCKVDNSSLTGESEP CCEECCCCCCCCCCC | 35.88 | 23927012 | |
217 (in isoform 4) | Phosphorylation | - | 35.88 | 24719451 | |
219 | Phosphorylation | KVDNSSLTGESEPQT EECCCCCCCCCCCCC | 40.63 | 23927012 | |
222 | Phosphorylation | NSSLTGESEPQTRSP CCCCCCCCCCCCCCC | 56.79 | 23927012 | |
226 | Phosphorylation | TGESEPQTRSPDFTN CCCCCCCCCCCCCCC | 43.78 | 23927012 | |
228 | Phosphorylation | ESEPQTRSPDFTNEN CCCCCCCCCCCCCCC | 32.01 | 21082442 | |
232 | Phosphorylation | QTRSPDFTNENPLET CCCCCCCCCCCCCCC | 49.34 | 29978859 | |
239 | Phosphorylation | TNENPLETRNIAFFS CCCCCCCCCCEEEEE | 36.38 | 29978859 | |
246 | Phosphorylation | TRNIAFFSTNCVEGT CCCEEEEECCCCCCC | 16.56 | 27050516 | |
253 | Phosphorylation | STNCVEGTARGIVVY ECCCCCCCCCEEEEE | 10.32 | 28857561 | |
260 | Phosphorylation | TARGIVVYTGDRTVM CCCEEEEECCCCCHH | 8.29 | 23927012 | |
260 (in isoform 4) | Phosphorylation | - | 8.29 | 24719451 | |
261 | Phosphorylation | ARGIVVYTGDRTVMG CCEEEEECCCCCHHH | 22.46 | 30266825 | |
264 | Methylation | IVVYTGDRTVMGRIA EEEECCCCCHHHHHH | 30.48 | - | |
265 | Phosphorylation | VVYTGDRTVMGRIAT EEECCCCCHHHHHHH | 21.42 | 22199227 | |
323 | Ubiquitination | TWLEAVIFLIGIIVA HHHHHHHHHHHHHHH | 3.06 | 22817900 | |
328 | Ubiquitination | VIFLIGIIVANVPEG HHHHHHHHHHCCCCC | 1.70 | 21890473 | |
346 | Ubiquitination | TVTVCLTLTAKRMAR HHHHHHHHHHHHHHH | 2.57 | 27667366 | |
354 | Ubiquitination | TAKRMARKNCLVKNL HHHHHHHCCCEECCH | 42.34 | 22817900 | |
356 | S-palmitoylation | KRMARKNCLVKNLEA HHHHHCCCEECCHHH | 5.32 | 21044946 | |
359 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 21890473 | |
359 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 21890473 | |
359 | Acetylation | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 27452117 | |
359 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 22817900 | |
359 (in isoform 1) | Ubiquitination | - | 42.75 | 21890473 | |
359 (in isoform 2) | Ubiquitination | - | 42.75 | 21890473 | |
369 | Phosphorylation | EAVETLGSTSTICSD HHHHHHCCCCCCCCC | 23.46 | 28857561 | |
369 (in isoform 4) | Phosphorylation | - | 23.46 | 24719451 | |
370 | Phosphorylation | AVETLGSTSTICSDK HHHHHCCCCCCCCCC | 28.26 | 28857561 | |
371 | Phosphorylation | VETLGSTSTICSDKT HHHHCCCCCCCCCCC | 19.92 | 28857561 | |
372 | Phosphorylation | ETLGSTSTICSDKTG HHHCCCCCCCCCCCC | 26.54 | 28857561 | |
375 | Phosphorylation | GSTSTICSDKTGTLT CCCCCCCCCCCCCCC | 37.99 | 28857561 | |
377 | Acetylation | TSTICSDKTGTLTQN CCCCCCCCCCCCCCC | 32.34 | 26051181 | |
377 | Ubiquitination | TSTICSDKTGTLTQN CCCCCCCCCCCCCCC | 32.34 | 27667366 | |
377 (in isoform 1) | Ubiquitination | - | 32.34 | 21890473 | |
377 (in isoform 2) | Ubiquitination | - | 32.34 | 21890473 | |
378 | Phosphorylation | STICSDKTGTLTQNR CCCCCCCCCCCCCCC | 40.15 | 28857561 | |
378 (in isoform 4) | Phosphorylation | - | 40.15 | 24719451 | |
380 | Phosphorylation | ICSDKTGTLTQNRMT CCCCCCCCCCCCCEE | 31.68 | 28857561 | |
382 | Phosphorylation | SDKTGTLTQNRMTVA CCCCCCCCCCCEEEE | 24.52 | 28857561 | |
402 | Phosphorylation | NQIHEADTTENQSGV CCCCCCCCCCCCCCC | 42.95 | 28348404 | |
403 | Phosphorylation | QIHEADTTENQSGVS CCCCCCCCCCCCCCC | 33.22 | 28348404 | |
407 | Phosphorylation | ADTTENQSGVSFDKT CCCCCCCCCCCCCHH | 53.39 | 26471730 | |
410 | Phosphorylation | TENQSGVSFDKTSAT CCCCCCCCCCHHHHH | 31.11 | 26471730 | |
413 | Ubiquitination | QSGVSFDKTSATWLA CCCCCCCHHHHHHHH | 42.23 | 23000965 | |
422 | Phosphorylation | SATWLALSRIAGLCN HHHHHHHHHHHHHHH | 18.94 | 24719451 | |
427 | Ubiquitination | ALSRIAGLCNRAVFQ HHHHHHHHHHHHHHH | 1.40 | 21963094 | |
437 | Ubiquitination | RAVFQANQENLPILK HHHHHHCHHCCHHHH | 43.93 | 23000965 | |
444 | Ubiquitination | QENLPILKRAVAGDA HHCCHHHHHHHCCCC | 38.74 | 21890473 | |
444 | Ubiquitination | QENLPILKRAVAGDA HHCCHHHHHHHCCCC | 38.74 | 21890473 | |
444 | 2-Hydroxyisobutyrylation | QENLPILKRAVAGDA HHCCHHHHHHHCCCC | 38.74 | - | |
444 | Acetylation | QENLPILKRAVAGDA HHCCHHHHHHHCCCC | 38.74 | 25038526 | |
444 | Ubiquitination | QENLPILKRAVAGDA HHCCHHHHHHHCCCC | 38.74 | 23000965 | |
444 (in isoform 1) | Ubiquitination | - | 38.74 | 21890473 | |
444 (in isoform 2) | Ubiquitination | - | 38.74 | 21890473 | |
445 | Ubiquitination | ENLPILKRAVAGDAS HCCHHHHHHHCCCCC | 30.74 | 27667366 | |
452 | Phosphorylation | RAVAGDASESALLKC HHHCCCCCHHHHHHH | 36.50 | 28857561 | |
454 | Phosphorylation | VAGDASESALLKCIE HCCCCCHHHHHHHHH | 23.01 | 28857561 | |
456 | Ubiquitination | GDASESALLKCIELC CCCCHHHHHHHHHHH | 6.99 | 23000965 | |
458 | Acetylation | ASESALLKCIELCCG CCHHHHHHHHHHHHC | 33.73 | 26051181 | |
458 | Ubiquitination | ASESALLKCIELCCG CCHHHHHHHHHHHHC | 33.73 | 21963094 | |
463 | Ubiquitination | LLKCIELCCGSVKEM HHHHHHHHHCCHHHH | 1.28 | 23000965 | |
466 | Phosphorylation | CIELCCGSVKEMRER HHHHHHCCHHHHHHH | 18.99 | 25159151 | |
468 | Acetylation | ELCCGSVKEMRERYA HHHHCCHHHHHHHHH | 47.71 | 25953088 | |
468 | Ubiquitination | ELCCGSVKEMRERYA HHHHCCHHHHHHHHH | 47.71 | 23000965 | |
476 | Ubiquitination | EMRERYAKIVEIPFN HHHHHHHEEEECCCC | 38.05 | 21890473 | |
476 | Ubiquitination | EMRERYAKIVEIPFN HHHHHHHEEEECCCC | 38.05 | 21890473 | |
476 | Ubiquitination | EMRERYAKIVEIPFN HHHHHHHEEEECCCC | 38.05 | 27667366 | |
476 (in isoform 1) | Ubiquitination | - | 38.05 | 21890473 | |
476 (in isoform 2) | Ubiquitination | - | 38.05 | 21890473 | |
477 | Ubiquitination | MRERYAKIVEIPFNS HHHHHHEEEECCCCC | 2.27 | 27667366 | |
484 | Phosphorylation | IVEIPFNSTNKYQLS EEECCCCCCCCEEEE | 33.46 | 28857561 | |
485 | Phosphorylation | VEIPFNSTNKYQLSI EECCCCCCCCEEEEE | 36.51 | 28857561 | |
487 | Ubiquitination | IPFNSTNKYQLSIHK CCCCCCCCEEEEEEC | 34.17 | 21890473 | |
487 | Ubiquitination | IPFNSTNKYQLSIHK CCCCCCCCEEEEEEC | 34.17 | 21890473 | |
487 | Acetylation | IPFNSTNKYQLSIHK CCCCCCCCEEEEEEC | 34.17 | 23236377 | |
487 | Malonylation | IPFNSTNKYQLSIHK CCCCCCCCEEEEEEC | 34.17 | 26320211 | |
487 | Ubiquitination | IPFNSTNKYQLSIHK CCCCCCCCEEEEEEC | 34.17 | 23000965 | |
487 (in isoform 1) | Ubiquitination | - | 34.17 | 21890473 | |
487 (in isoform 2) | Ubiquitination | - | 34.17 | 21890473 | |
488 | Phosphorylation | PFNSTNKYQLSIHKN CCCCCCCEEEEEECC | 19.43 | 28442448 | |
494 | Ubiquitination | KYQLSIHKNPNTSEP CEEEEEECCCCCCCC | 72.87 | 21890473 | |
494 | Ubiquitination | KYQLSIHKNPNTSEP CEEEEEECCCCCCCC | 72.87 | 21890473 | |
494 | Acetylation | KYQLSIHKNPNTSEP CEEEEEECCCCCCCC | 72.87 | 26051181 | |
494 | Methylation | KYQLSIHKNPNTSEP CEEEEEECCCCCCCC | 72.87 | - | |
494 | Ubiquitination | KYQLSIHKNPNTSEP CEEEEEECCCCCCCC | 72.87 | 23000965 | |
494 (in isoform 1) | Ubiquitination | - | 72.87 | 21890473 | |
494 (in isoform 2) | Ubiquitination | - | 72.87 | 21890473 | |
495 | Ubiquitination | YQLSIHKNPNTSEPQ EEEEEECCCCCCCCC | 22.38 | 23000965 | |
498 | Phosphorylation | SIHKNPNTSEPQHLL EEECCCCCCCCCEEE | 35.41 | 20873877 | |
499 | Phosphorylation | IHKNPNTSEPQHLLV EECCCCCCCCCEEEE | 54.65 | 20873877 | |
499 (in isoform 4) | Phosphorylation | - | 54.65 | 27251275 | |
504 | Ubiquitination | NTSEPQHLLVMKGAP CCCCCCEEEEECCCH | 3.04 | 22817900 | |
508 | Ubiquitination | PQHLLVMKGAPERIL CCEEEEECCCHHHHH | 44.43 | 21890473 | |
508 | Ubiquitination | PQHLLVMKGAPERIL CCEEEEECCCHHHHH | 44.43 | 21890473 | |
508 | Acetylation | PQHLLVMKGAPERIL CCEEEEECCCHHHHH | 44.43 | 27452117 | |
508 | Ubiquitination | PQHLLVMKGAPERIL CCEEEEECCCHHHHH | 44.43 | 27667366 | |
508 (in isoform 1) | Ubiquitination | - | 44.43 | 21890473 | |
508 (in isoform 2) | Ubiquitination | - | 44.43 | 21890473 | |
517 | Methylation | APERILDRCSSILLH CHHHHHHHHHHHHHC | 20.83 | - | |
518 | Glutathionylation | PERILDRCSSILLHG HHHHHHHHHHHHHCC | 3.60 | 22555962 | |
518 | S-palmitoylation | PERILDRCSSILLHG HHHHHHHHHHHHHCC | 3.60 | 21044946 | |
519 | Phosphorylation | ERILDRCSSILLHGK HHHHHHHHHHHHCCC | 22.70 | 28348404 | |
520 | Phosphorylation | RILDRCSSILLHGKE HHHHHHHHHHHCCCC | 22.38 | 28348404 | |
526 | 2-Hydroxyisobutyrylation | SSILLHGKEQPLDEE HHHHHCCCCCCCCHH | 42.29 | - | |
526 | Sumoylation | SSILLHGKEQPLDEE HHHHHCCCCCCCCHH | 42.29 | - | |
526 | Ubiquitination | SSILLHGKEQPLDEE HHHHHCCCCCCCCHH | 42.29 | 23000965 | |
526 (in isoform 1) | Ubiquitination | - | 42.29 | 21890473 | |
535 | Ubiquitination | QPLDEELKDAFQNAY CCCCHHHHHHHHHHH | 50.74 | 21906983 | |
535 (in isoform 1) | Ubiquitination | - | 50.74 | 21890473 | |
535 (in isoform 2) | Ubiquitination | - | 50.74 | 21890473 | |
542 | Phosphorylation | KDAFQNAYLELGGLG HHHHHHHHHHHCCHH | 14.30 | 27273156 | |
574 | Ubiquitination | EGFQFDTDDVNFPID CCCCCCCCCCCCCCC | 60.76 | 23000965 | |
581 | Ubiquitination | DDVNFPIDNLCFVGL CCCCCCCCCEEEEHH | 42.14 | 22817900 | |
594 | Ubiquitination | GLISMIDPPRAAVPD HHHHCCCCCCCCCCC | 14.89 | 23000965 | |
598 | Ubiquitination | MIDPPRAAVPDAVGK CCCCCCCCCCCHHHH | 18.04 | 23000965 | |
605 | 2-Hydroxyisobutyrylation | AVPDAVGKCRSAGIK CCCCHHHHHHHCCCE | 21.63 | - | |
605 | Ubiquitination | AVPDAVGKCRSAGIK CCCCHHHHHHHCCCE | 21.63 | 23000965 | |
605 (in isoform 1) | Ubiquitination | - | 21.63 | 21890473 | |
605 (in isoform 2) | Ubiquitination | - | 21.63 | 21890473 | |
608 | Phosphorylation | DAVGKCRSAGIKVIM CHHHHHHHCCCEEEE | 40.07 | 20068231 | |
612 | 2-Hydroxyisobutyrylation | KCRSAGIKVIMVTGD HHHHCCCEEEEEECC | 25.45 | - | |
612 | Acetylation | KCRSAGIKVIMVTGD HHHHCCCEEEEEECC | 25.45 | 26051181 | |
612 | Ubiquitination | KCRSAGIKVIMVTGD HHHHCCCEEEEEECC | 25.45 | 22817900 | |
612 (in isoform 1) | Ubiquitination | - | 25.45 | 21890473 | |
612 (in isoform 2) | Ubiquitination | - | 25.45 | 21890473 | |
617 | Phosphorylation | GIKVIMVTGDHPITA CCEEEEEECCCCCCH | 21.36 | 20068231 | |
623 | Phosphorylation | VTGDHPITAKAIAKG EECCCCCCHHHHHHC | 26.93 | 20068231 | |
625 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 21890473 | |
625 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 21890473 | |
625 | 2-Hydroxyisobutyrylation | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | - | |
625 | Acetylation | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 27452117 | |
625 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 23000965 | |
625 (in isoform 1) | Ubiquitination | - | 31.51 | 21890473 | |
625 (in isoform 2) | Ubiquitination | - | 31.51 | 21890473 | |
629 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 21890473 | |
629 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 21890473 | |
629 | 2-Hydroxyisobutyrylation | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | - | |
629 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 23000965 | |
629 (in isoform 1) | Ubiquitination | - | 48.27 | 21890473 | |
629 (in isoform 2) | Ubiquitination | - | 48.27 | 21890473 | |
630 | Ubiquitination | TAKAIAKGVGIISEG CHHHHHHCCEEEECC | 17.54 | 27667366 | |
635 | Phosphorylation | AKGVGIISEGNETVE HHCCEEEECCCCCHH | 37.21 | 25072903 | |
635 (in isoform 2) | Phosphorylation | - | 37.21 | 20860994 | |
638 (in isoform 2) | Phosphorylation | - | 37.40 | 20860994 | |
640 | Phosphorylation | IISEGNETVEDIAAR EEECCCCCHHHHHHH | 32.94 | 24076635 | |
640 | Ubiquitination | IISEGNETVEDIAAR EEECCCCCHHHHHHH | 32.94 | 21963094 | |
642 (in isoform 2) | Phosphorylation | - | 51.63 | 20860994 | |
652 | Neddylation | AARLNIPVSQVNPRD HHHCCCCHHHCCHHH | 5.75 | 32015554 | |
652 | Ubiquitination | AARLNIPVSQVNPRD HHHCCCCHHHCCHHH | 5.75 | 21963094 | |
653 | Phosphorylation | ARLNIPVSQVNPRDA HHCCCCHHHCCHHHC | 24.05 | 30266825 | |
653 (in isoform 4) | Phosphorylation | - | 24.05 | 24719451 | |
661 | 2-Hydroxyisobutyrylation | QVNPRDAKACVVHGS HCCHHHCCEEEEECH | 46.75 | - | |
661 | Acetylation | QVNPRDAKACVVHGS HCCHHHCCEEEEECH | 46.75 | 25953088 | |
661 | Succinylation | QVNPRDAKACVVHGS HCCHHHCCEEEEECH | 46.75 | - | |
661 | Succinylation | QVNPRDAKACVVHGS HCCHHHCCEEEEECH | 46.75 | - | |
661 | Ubiquitination | QVNPRDAKACVVHGS HCCHHHCCEEEEECH | 46.75 | 27667366 | |
663 | Glutathionylation | NPRDAKACVVHGSDL CHHHCCEEEEECHHH | 3.02 | 22555962 | |
663 | S-palmitoylation | NPRDAKACVVHGSDL CHHHCCEEEEECHHH | 3.02 | 21044946 | |
667 | Ubiquitination | AKACVVHGSDLKDMT CCEEEEECHHHHCCC | 15.96 | 23000965 | |
668 | Phosphorylation | KACVVHGSDLKDMTS CEEEEECHHHHCCCH | 25.54 | 28985074 | |
671 | Acetylation | VVHGSDLKDMTSEQL EEECHHHHCCCHHHH | 50.90 | 25953088 | |
671 | Ubiquitination | VVHGSDLKDMTSEQL EEECHHHHCCCHHHH | 50.90 | 21963094 | |
674 | Phosphorylation | GSDLKDMTSEQLDDI CHHHHCCCHHHHHHH | 38.97 | 27732954 | |
675 | Phosphorylation | SDLKDMTSEQLDDIL HHHHCCCHHHHHHHH | 19.39 | 24076635 | |
683 | Ubiquitination | EQLDDILKYHTEIVF HHHHHHHHHHHEEEE | 35.01 | 21890473 | |
683 | 2-Hydroxyisobutyrylation | EQLDDILKYHTEIVF HHHHHHHHHHHEEEE | 35.01 | - | |
683 | Neddylation | EQLDDILKYHTEIVF HHHHHHHHHHHEEEE | 35.01 | 32015554 | |
683 | Ubiquitination | EQLDDILKYHTEIVF HHHHHHHHHHHEEEE | 35.01 | 21963094 | |
683 (in isoform 1) | Ubiquitination | - | 35.01 | 21890473 | |
684 | Phosphorylation | QLDDILKYHTEIVFA HHHHHHHHHHEEEEE | 15.55 | 24927040 | |
686 | Phosphorylation | DDILKYHTEIVFART HHHHHHHHEEEEEEC | 25.07 | 26356563 | |
695 | Ubiquitination | IVFARTSPQQKLIIV EEEEECCCCCEEEEE | 39.75 | 27667366 | |
696 | Ubiquitination | VFARTSPQQKLIIVE EEEECCCCCEEEEEE | 53.46 | 22817900 | |
698 | 2-Hydroxyisobutyrylation | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | - | |
698 | Acetylation | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | 27452117 | |
698 | Ubiquitination | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | 23000965 | |
698 (in isoform 1) | Ubiquitination | - | 36.08 | 21890473 | |
705 | Glutathionylation | KLIIVEGCQRQGAIV EEEEEECCCCCCCEE | 1.58 | 22555962 | |
705 | S-palmitoylation | KLIIVEGCQRQGAIV EEEEEECCCCCCCEE | 1.58 | 29575903 | |
715 | Phosphorylation | QGAIVAVTGDGVNDS CCCEEEEECCCCCCC | 21.59 | 24076635 | |
722 | Phosphorylation | TGDGVNDSPALKKAD ECCCCCCCHHHHHCC | 13.58 | 29255136 | |
722 (in isoform 4) | Phosphorylation | - | 13.58 | 24719451 | |
726 | Ubiquitination | VNDSPALKKADIGVA CCCCHHHHHCCCEEE | 48.28 | 21906983 | |
726 (in isoform 1) | Ubiquitination | - | 48.28 | 21890473 | |
727 | Ubiquitination | NDSPALKKADIGVAM CCCHHHHHCCCEEEC | 52.74 | 21906983 | |
727 (in isoform 1) | Ubiquitination | - | 52.74 | 21890473 | |
734 | Sulfoxidation | KADIGVAMGIAGSDV HCCCEEECCCCCCHH | 3.56 | 28183972 | |
739 | Phosphorylation | VAMGIAGSDVSKQAA EECCCCCCHHHHHHH | 26.30 | 22210691 | |
742 | Phosphorylation | GIAGSDVSKQAADMI CCCCCHHHHHHHCEE | 24.84 | 20068231 | |
742 | Ubiquitination | GIAGSDVSKQAADMI CCCCCHHHHHHHCEE | 24.84 | 21963094 | |
743 | Ubiquitination | IAGSDVSKQAADMIL CCCCHHHHHHHCEEE | 43.75 | 22817900 | |
748 | Sulfoxidation | VSKQAADMILLDDNF HHHHHHCEEEECCCC | 1.67 | 28183972 | |
773 | Acetylation | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 27178108 | |
773 | Succinylation | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 23954790 | |
773 | Ubiquitination | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 21963094 | |
773 (in isoform 1) | Ubiquitination | - | 51.21 | 21890473 | |
774 | Ubiquitination | LIFDNLKKSIAYTLT EEECCHHHHHHHHHH | 50.70 | 22817900 | |
809 | Ubiquitination | LGTVTILCIDLGTDM CCCEEEEEEECCCCH | 1.69 | 23000965 | |
812 | Ubiquitination | VTILCIDLGTDMVPA EEEEEEECCCCHHHH | 3.95 | 23000965 | |
833 | Ubiquitination | QAESDIMKRQPRNPK HHHHHHHHCCCCCCC | 48.49 | - | |
840 | Ubiquitination | KRQPRNPKTDKLVNE HCCCCCCCHHHHHHH | 73.27 | 23000965 | |
840 (in isoform 1) | Ubiquitination | - | 73.27 | 21890473 | |
843 | 2-Hydroxyisobutyrylation | PRNPKTDKLVNERLI CCCCCHHHHHHHHHH | 60.61 | - | |
843 | Acetylation | PRNPKTDKLVNERLI CCCCCHHHHHHHHHH | 60.61 | 26210075 | |
843 | Ubiquitination | PRNPKTDKLVNERLI CCCCCHHHHHHHHHH | 60.61 | 23000965 | |
843 (in isoform 1) | Ubiquitination | - | 60.61 | 21890473 | |
901 | Phosphorylation | WINDVEDSYGQQWTY CHHCCHHHHCCCCCC | 20.05 | 22468782 | |
902 | Phosphorylation | INDVEDSYGQQWTYE HHCCHHHHCCCCCCH | 31.13 | 22468782 | |
907 | Phosphorylation | DSYGQQWTYEQRKIV HHHCCCCCCHHHHEE | 16.91 | 22468782 | |
919 | Ubiquitination | KIVEFTCHTAFFVSI HEEEHHHCHHHHHHH | 19.71 | 27667366 | |
921 | Ubiquitination | VEFTCHTAFFVSIVV EEHHHCHHHHHHHHH | 3.39 | 22817900 | |
943 | Phosphorylation | ICKTRRNSVFQQGMK EECCCCCHHHHHHCC | 23.61 | 15621037 | |
949 | Sulfoxidation | NSVFQQGMKNKILIF CHHHHHHCCCCEEEE | 3.62 | 28183972 | |
950 | 2-Hydroxyisobutyrylation | SVFQQGMKNKILIFG HHHHHHCCCCEEEEE | 63.01 | - | |
950 | Ubiquitination | SVFQQGMKNKILIFG HHHHHHCCCCEEEEE | 63.01 | 27667366 | |
950 (in isoform 1) | Ubiquitination | - | 63.01 | 21890473 | |
952 | Ubiquitination | FQQGMKNKILIFGLF HHHHCCCCEEEEECC | 33.11 | 22817900 | |
988 | Ubiquitination | YPLKPTWWFCAFPYS CCCCCCHHHCCCCHH | 4.86 | 21890473 | |
1019 | Ubiquitination | RPGGWVEKETYY--- CCCCCCCCCCCC--- | 45.82 | 21890473 | |
1019 | 2-Hydroxyisobutyrylation | RPGGWVEKETYY--- CCCCCCCCCCCC--- | 45.82 | - | |
1019 | Ubiquitination | RPGGWVEKETYY--- CCCCCCCCCCCC--- | 45.82 | 27667366 | |
1019 (in isoform 1) | Ubiquitination | - | 45.82 | 21890473 | |
1021 | Phosphorylation | GGWVEKETYY----- CCCCCCCCCC----- | 38.91 | - |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
943 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT1A1_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
D00112 | G-Strophanthin (JAN); Ouabain; Ouabain octahydrate |
D00297 | Digitoxin (JP16/USP/INN); Crystodigin (TN) |
D00298 | Digoxin (JP16/USP); Lanoxicaps (TN); Lanoxin (TN) |
D01240 | Deslanoside (JP16/USP/INN); Cedilanid-d (TN) |
D01379 | Proscillaridin (JAN/USAN/INN); Talusin (TN) |
D01972 | Lanatoside C (JP16/INN); Digilanogen C (TN) |
D02587 | Metildigoxin (JP16); Lanirapid (TN) |
D06881 | Acetyldigitoxin (INN); Acylanid (TN) |
D07147 | Gitoformate (INN) |
D07555 | Acetyldigoxin; Cedigossima (TN) |
D07556 | beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) |
D09847 | Metildigoxin (INN); Medigoxin (BAN) |
DrugBank | |
DB00511 | Acetyldigitoxin |
DB01430 | Almitrine |
DB01370 | Aluminium |
DB01244 | Bepridil |
DB01158 | Bretylium |
DB01188 | Ciclopirox |
DB01078 | Deslanoside |
DB01119 | Diazoxide |
DB01396 | Digitoxin |
DB00390 | Digoxin |
DB00903 | Ethacrynic acid |
DB00774 | Hydroflumethiazide |
DB01092 | Ouabain |
DB01021 | Trichlormethiazide |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND TYR-260, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-260, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-10; TYR-55 AND TYR-260,AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-260, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-260, AND MASSSPECTROMETRY. |